HomeHealthcare & Life SciencesBiotechnology Lung In Vitro Model Market

Australia Lung In Vitro Model Market Size & Outlook, 2026-2034


Australia Lung In Vitro Model Market Insights

  • Based on Reed Intelligence findings, the Australia Lung In Vitro Model Market reached USD 106.64 Million in 2025 and is estimated to attain USD 255.18 Million by 2034.
  • From 2026 to 2034, the Australia market is expected to grow at a steady CAGR of 10.24%.
  • Within the Type category, 2D Lung Models dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Lung-on-Chip Models is forecasted to deliver the fastest growth, positioning it as the most lucrative Type segment.

Other Key Findings


  • Australia accounted for 0.75% of the global Lung In Vitro Model Market size in 2025.
  • By 2034, United States is expected to remain the top global market in terms of size.
  • Within Asia Pacific, China is forecasted to dominate the regional Lung In Vitro Model Market size by 2034.
  • South East Asia will be the fastest-growing market in Asia Pacific, projected to achieve USD 528.57 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 106.64 Million
Market Size In 2034 USD 255.18 Million
Largest segment 2D Lung Models
Units Revenue in USD Million
CAGR 10.24% (2026-2034)
Segmnetation Covered
Type
  1. 2D Lung Models
  2. 3D Lung Models
  3. Lung-on-Chip Models
Application
  1. Drug Discovery
  2. Toxicity Testing
  3. Disease Modeling
End-Use
  1. Pharmaceutical & Biotechnology Companies
  2. Academic & Research Institutes
  3. Contract Research Organizations
Technology
  1. Cell Culture-Based Models
  2. Microfluidic Systems
  3. Bioprinting Technologies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports